739
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Exploring QSARs of the interaction of flavonoids with GABA (A) receptor using MLR, ANN and SVM techniques

, &
Pages 670-676 | Received 16 Jul 2013, Accepted 22 Aug 2013, Published online: 09 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vinicius Gonçalves Maltarollo, Thales Kronenberger, Gabriel Zarzana Espinoza, Patricia Rufino Oliveira & Kathia Maria Honorio. (2019) Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery 14:1, pages 23-33.
Read now

Articles from other publishers (7)

José-Luis Ríos, Guillermo R. Schinella & Inés Moragrega. (2022) Phenolics as GABAA Receptor Ligands: An Updated Review. Molecules 27:6, pages 1770.
Crossref
Eileen Carry, Dushyant Kshatriya, Joshua Silva, Daryl L. Davies, Bo Yuan, Qingli Wu, Harna Patel, Elizabeth R. Park, John Gilleran, Lihong Hao, Jacques Roberge, Nicholas T. Bello & James E. Simon. (2021) Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice. International Journal of Molecular Sciences 22:14, pages 7460.
Crossref
Bo Fan, Yunfei Li, Yong Bi, Ling Tong, Dongxiang Li & Yi Wang. (2019) Design of multi-drug combinations for poly-pharmacological effects using composition-activity relationship modeling and multi-objective optimization approach: Application in traditional Chinese medicine. Chemical Biology & Drug Design 93:6, pages 1073-1082.
Crossref
Alla P. Toropova, Andrey A. Toropov & Emilio Benfenati. (2018) Semi-correlations as a tool to build up categorical (active/inactive) model of GABAA receptor modulator activity. Structural Chemistry 30:3, pages 853-861.
Crossref
Hossein Hosseinzadeh & Marjan Nassiri-Asl. 2017. Neuroprotective Natural Products. Neuroprotective Natural Products 279 291 .
Omar Deeb & Mohammad Goodarzi. 2017. Oncology. Oncology 408 433 .
Omar Deeb & Mohammad Goodarzi. 2015. Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment. Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment 212 237 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.